Activation of Src protein tyrosine kinase plays an essential role in urocortin-mediated cardioprotection

Molecular and Cellular Endocrinology

Volumn 325, Issue 1-2, 2010, Pages 1-7

  Yuan, Zhaokan ^a,b   McCauley, Roy ^b   Chen Scarabelli, Carol ^a,c   Abounit, Kadija ^a,b   Stephanou, Anastasis ^d   Barry, Sean P ^e   Knight, Richard ^d   Saravolatz, Samuel F ^a   Saravolatz, Louis D ^a   Ulgen, Berkin O ^a   Scarabelli, Gabriele M ^a   Faggian, Giuseppe ^e   Mazzucco, Alessandro ^e   Saravolatz, Louis ^a   Scarabelli, Tiziano M ^a,b  

^a ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF VERONA   (Italy)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; Cardioprotection; ERK1 2; Src; Urocortin

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; CASPASE 3; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXYGEN; PROTEIN TYROSINE KINASE; TYROSINE; UROCORTIN;

ANIMAL CELL; ARTICLE; CELL HYPOXIA; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HEART MUSCLE CELL; HEART PROTECTION; INCUBATION TIME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SECRETION; PROTEIN SYNTHESIS; REOXYGENATION; TITRIMETRY;

ANIMALS; CARDIOTONIC AGENTS; CELLS, CULTURED; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HEART; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIUM; MYOCYTES, CARDIAC; PROTEIN KINASE INHIBITORS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SRC-FAMILY KINASES; UROCORTINS;

EID: 77954384763     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.04.013     Document Type: Article

References (35)

1. Brar B.K., Chen A., Perrin M.H., Vale W. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides. Endocrinology 2004, 145:1718-1729.
2. Brar B.K., Stephanou A., Knight R., Latchman D.S. Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death. J. Mol. Cell. Cardiol. 2002, 34:483-492.
3. Brar B.K., Jonassen A.K., Stephanou A., Santilli G., Railson J., knight R.A., Yellon D.M., Latchman D.S. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J. Biol. Chem. 2000, 275:8508-8514.
4. Brar B.K., Stephanou A., Okosi A., Lawrence K.M., Knight R.A., Marber M.S., Latchman D.S. CRH-like peptides protect cardiac myocytes from lethal ischaemic injury. Mol. Cell. Endocrinol. 1999, 158:55-63.
5. Chen-Scarabelli C., Faggian G., Yuan Z., Tessari M., Rungatscher A., Di Rezze J., Scarabelli G.M., Abounit K., McCauley R., Saravolatz L., Mazzucco A., Scarabelli T.M. Warm-blood cardioplegic arrest induces selective mitochondrial translocation of protein kinase C epsilon followed by interaction with 6.1 inwardly rectifying potassium channel subunit in viable myocytes overexpressing urocortin. J. Thorac. Cardiovasc. Surg. 2009, 138(5):1213-1221.
6. Grammatopoulos D.K., Randeva H.S., Levine M.A., Katsanou E.S., Hillhouse E.W. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins. Mol. Endocrinol. 2000, 14:2076-2091.
7. +-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J. Biol. Chem. 2002, 277:18694-18702.
8. Hillhouse E.W., Grammatopoulos D.K. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr. Rev. 2006, 27:260-286.
9. Knight R.A., Chen-Scarabelli C., Yuan Z., McCauley R.B., Di Rezze J., Scarabelli G.M., Townsend P.A., Latchman D., Saravolatz L., Faggian G., Mazzucco A., Chowdrey H.S., Stephanou A., Scarabelli T.M. Cardiac release of urocortin precedes the occurrence of irreversible myocardial damage in the rat heart exposed to ischemia/reperfusion injury. FEBS Lett. 2008, 582:984-990.
10. Lawrence K.M., Kabir A.M., Bellahcene M., Davidson S., Cao X.B., McCormick J., Mesquita R.A., Carroll C.J., Chanalaris A., Townsend P.A., Hubank M., Stephanou A., Knight R.A., Marber M.S., Latchman D.S. Cardioprotection mediated by urocortin is dependent on PKCepsilon activation. FASEB J. 2005, 19:831-833.
11. Lawrence K.M., Scarabelli T.M., Turtle L., Chanalaris A., Townsend P.A., Carroll C.J., Hubank M., Stephanou A., Knight R.A., Latchman D.S. Urocortin protects cardiac myocytes from ischemia/reperfusion injury by attenuating calcium-insensitive phospholipase A2 gene expression. FASEB J. 2003, 17:2313-2315.
12. Lawrence K.M., Chanalaris A., Scarabelli T.M., Hubank M., Pasini E., Townsend P.A., Comini L., Ferrari R., Tinker A., Stephanou A., Knight R.A., Latchman D.S. K(ATP) channel gene expression is induced by urocortin and mediates its cardioprotective effect. Circulation 2002, 106:1556-1562.
13. Liebmann C. Regulation of MAP kinase activity by peptide receptor signaling pathway: paradigms of multiplicity. Cell Signal. 2001, 13:777-785.
14. Luttrell D.K., Luttrell L.M. Not so strange bedfellows: G-protein-coupled receptors and Src family kinases. Oncogene 2004, 23:7969-7978.
15. Martin G.S. The hunting of the Src. Nat. Rev. Mol. Cell Biol. 2001, 2:467-475.
16. Okosi A., Brar B.K., Chan M., D'Souza L., Smith E., Stephanou A., Latchman D.S., Chowdrey H.S., Knight R.A. Expression and protective effects of urocortin in cardiac myocytes. Neuropeptides 1998, 32:167-171.
17. Oldenburg O., Qin Q., Krieq T., Yang X.M., Philipp S., Critz S.D., Cohen M.V., Downey J.M. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H468-476.
18. Onishi A., Chen Q., Humtsoe J.O., Kramer R.H. STAT3 signaling is induced by intercellular adhesion in squamous cell carcinoma cells. Exp. Cell Res. 2008, 314:377-386.
19. Ozawa Y., Williams A.H., Estes M.L., Matsushita N., Boschelli F., Jove R., List A.F. Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT). Leuk. Res. 2008, 32:893-903.
20. Papadopoulou N., Chen J., Randeva H.S., Levine M.A., Hillhouse E.W., Grammatopoulos D.K. Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity. Mol. Endocrinol. 2004, 18:624-639.
21. Pedersen W.A., Wan R., Zhang P., Mattson P. Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I. J. Neurosci. 2002, 22:404-412.
22. Perrin M.H., Vale W.W. Corticotropin releasing factor receptors and their ligand family. Ann. N. Y. Acad. Sci. 1999, 885:312-328.
23. +-ATPase signaling cascade in rat hearts. Cardiovasc. Res. 2007, 73:488-496.
24. Rozengurt E. Mitogenic signaling pathways induced by G protein-coupled receptors. J. Cell. Physiol. 2007, 213:589-602.
25. Ruhmann A., Bonk I., Lin C.R., Rosenfeld M.G., Spiess J. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:15264-15269.
26. Scarabelli T., Knight R. Urocortins: take them to heart. Curr. Med. Chem. Cardiovasc. Hematol. Agents 2004, 2:187-196.
27. Scarabelli T.M., Pasini E., Ferrari G., Ferrari M., Stephanou A., Lawrence K., Townsend P., Chen-Scarabelli C., Gitti G., Saravolatz L., Latchman D., Knight R.A., Gardin J.M. Warm blood cardioplegic arrest induces mitochondrial-mediated cardiomyocyte apoptosis associated with increased urocortin expression in viable cells. J. Thorac. Cardiovasc. Surg. 2004, 128:364-371.
28. Scarabelli T.M., Stephanou A., Pasini E., Gitti G., Townsend P., Lawrence K., Chen-Scarabelli C., Saravolatz L., Latchman D., Knight R., Gardin J. Minocycline inhibits caspase activation and reactivation, increases the ratio of xiap to smac/Diablo and reduces the mitochondrial leakage of cytochrome c and smac/Diablo. J. Am. Coll. Cardiol. 2004, 43:865-874.
29. Scarabelli T.M., Pasini E., Stephanou A., Comini L., Curello S., Raddino R., Ferrari R., Knight R., Latchman D.S. Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion. J. Am. Coll. Cardiol. 2002, 40:155-161.
30. Schulman D., Latchman D.S., Yellon D.M. Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H1481-1488.
31. Sun Y., Huang J., Xiang Y., Bastepe M., Juppner H., Kobilka B.K., Zhang J.J., Huang X.Y. Dosage-dependent switch from G protein-coupled to G protein-independent signaling by a GPCR. EMBO J. 2007, 26:53-64.
32. Thomas S.M., Brugge J.S. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 1997, 13:513-609.
33. +-ATPase forms a functional signaling complex. Mol. Biol. Cell 2006, 17:317-326.
34. Tsuruda A., Suzuki S., Maekawa T., Oka S. Constitutively active Src facilitates NGF-induced phosphorylation of TrkA and causes enhancement of the MAPK signaling in SK-N-MC cells. FEBS Lett. 2004, 560:215-220.
35. Yeatman T.J. A renaissance for Src. Nat. Rev. Cancer 2004, 4:470-480.